Preventing acute kidney injury after noncardiac surgery

Current Opinion in Critical Care

Volumn 16, Issue 4, 2010, Pages 353-358

  Brienza, Nicola ^a   Giglio, Maria T ^a   Marucci, Massimo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Perioperative hemodynamic optimization; Postoperative acute kidney injury; Renal risk stratification; Renoprotection

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BICARBONATE; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; FENOLDOPAM MESILATE; GLUCOSE; INFUSION FLUID; INOTROPIC AGENT; INSULIN; POLYMYXIN B; PROSTAGLANDIN;

ABDOMINAL INFECTION; ABDOMINAL PRESSURE; ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; ARTIFICIAL VENTILATION; BLOOD VOLUME; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SURGERY; CELL DAMAGE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CRYSTALLOID; DISEASE SEVERITY; EMERGENCY SURGERY; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL RENAL REPLACEMENT THERAPY; FLUID BALANCE; FLUID THERAPY; GENERAL SURGERY; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GOAL DIRECTED THERAPY; HEART OUTPUT; HEART SURGERY; HEMODIALYSIS; HEMODYNAMIC MONITORING; HEMOPERFUSION; HUMAN; HYPOVOLEMIA; INTENSIVE CARE; INTRAABDOMINAL HYPERTENSION; KIDNEY INJURY; KIDNEY TUBULE CELL; LOW DRUG DOSE; METABOLIC REGULATION; MORTALITY; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROSTAGLANDIN RELEASE; PULMONARY ARTERY CATHETER; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESUSCITATION; REVIEW; SEPSIS; SURGICAL PATIENT; URINE VOLUME;

ACUTE DISEASE; ACUTE KIDNEY INJURY; ATRIAL NATRIURETIC FACTOR; CARDIAC OUTPUT; FENOLDOPAM; HEMODYNAMICS; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TIME FACTORS; VASODILATOR AGENTS;

EID: 78449296197     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32833a9ef5     Document Type: Review

References (56)

1. Carmichael P, Carmichael AR. Acute renalfailure in thesurgicalsetting. ANZJ Surg 2003; 73:144-153.
2. Tang I, Murray PT. Prevention of perioperative acute renal failure: what works? Best Prac Res Clin Anaesth 2004; 18:91-111.
3. Aronson S, Blumenthal R. Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J Cardiothorac Vasc Anesth 1998; 12:567-586.
4. Thakar CV, Yared JP, Worley S, et al. Renal dysfunction and serious infections after open-heart surgery. Kidney Int 2003; 64:239-246.
5. Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Complications and costs after high-risksurgery: where should we focus quality improvement initiatives? J Am Coll Surg 2003; 196:671-678.
6. Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 2008; 36:1129-1137.
7. Kheterpal S, Tremper KK, Englesbe MJ, et al. Predictors of postoperative acute renal failure after non cardiac surgery in patients with previously normal renal function. Anesthesiology 2007; 107:892-902.
8. Druml W. Long-term prognosis of patients with acute renal failure: is intensive care worth it? Intensive Care Med 2005; 31:1145-1147.
9. Bagshaw SM. The long-term outcome after acute renal failure. Curr Opin Crit Care 2006; 12:561-566.
10. Novis BK, Roizen MF, Aronson S, et al.Association ofpreoperative riskfactors with postoperative acute renal failure. Anesth Analg 1994; 78:143-149.
11. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10:R73.
12. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
13. Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinaseassociated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54:1012-1024.
14. Reddy VG. Prevention of postoperative acute renal failure. J Postgrad Med 2002; 48:64-70.
15. Kheterpal S, Tremper KK, Heung M, et al. Development and validation of an acute kidney injury riskindexforpatients undergoing general surgery. Results from a national data set. Anesthesiology 2009; 110:505-515.
16. Abelha FJ, Botelho M, Fernandes V, Barros H. Determinants of postoperative acute kidney injury. Crit Care 2009; 13:R79.
17. Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 2009; 249:851-858.
18. Khuri SF, Henderson WG, DePalma RG, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complica-tions. Ann Surg 2005; 242:326-343.
19. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997; 95:878-884.
20. Zacharias M,Gilmore IC, Herbison GP, et al. Interventionsforprotecting renal function in the perioperative period. Cochrane Database Syst Rev 2005:CD003590.
21. Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: expert opinion of the working group for nephrology, ESICM. Intensive Care Med 2010; 36:392-411.
22. Davenport A. Clinical guidelines for the protection of kidney function and prevention of acute kidney injury in the intensive care unit: common sense rather than magic bullets? Intensive Care Med 2010; 36:379-380.
23. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group.Ann Intern Med 1998; 128:194-203.
24. Whittemore AD, Clowes AW, Hechtman HB, Mannick JA. Aortic aneurysm repair: reduced operative mortality associated with maintenance of optimal cardiac performance.Ann Surg 1980; 192:414-421.
25. Hesdorffer CS, Milne JF, Meyers AM, et al. The value of Swan Ganz catheterization and volume loading in preventing renal failure in patients undergoing abdominal aneurysmectomy. Clin Nephrol 1987; 28:272-276.
26. Brandstrup B, Svensen C, Engquist A. Hemorrhage and operation cause a contraction of the extracellular space needing replacement: evidence and implications? A systematic review. Surgery 2006; 139:419-432.
27. Rahbari NN, Zimmermann JB, Schmidt T, et al. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg 2009; 96:331-341.
28. Biancofiore G, Bindi ML, Romanelli AM, et al. Intra-abdominal pressure monitoring in liver transplant recipients: a prospective study. Intensive Care Med 2003; 29:30-36.
29. Balogh Z, McKinley BA, Cocanour CS, et al. Supranormal trauma resuscita-tion causes more cases of abdominal compartment syndrome. Arch Surg 2003; 138:637-642.
30. McNelis J, Marini CP, Jurkiewicz A, et al. Predictivefactorsassociated withthe development of abdominal compartment syndrome in the surgical intensive care unit Arch Surg 2002; 137:133-136.
31. Sugrue M, Jones F, Deane SA, et al. Intra-abdominal hypertension is an independent cause of postoperative renal impairment. Arch Surg 1999; 134:1082-1085.
32. McDougall EM, Monk TG, Wolf JS Jr, et al. The effect of prolonged pneu-moperitoneum on renal function in an animal model. J Am Coll Surg 1996; 182:317-328.
33. Dalfino L, Tullo L, Donadio I, et al. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med 2008; 34:707-713.
34. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723-740.
35. Shoemaker WC, Appel PL, Kram HB. Haemodynamic and oxygen transport responses in survivors and nonsurvivors of high-risk surgery. Crit Care Med 1993; 21:977-990.
36. Brienza N, Giglio MT, Marucci M, Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 2009; 37:2079-2090.
37. Heringlake M, Wernerus M, Grunefeld J, et al.The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care 2007; 11:R51.
38. Boldt J, Brosch C, Rohm K, et al. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 2008; 100: 457-464.
39. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007; 94:427-433.
40. Schabinski F, Oishi J, Tuche F, et al. Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 2009; 35:1539-1547.
41. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus otherfluid therapies: effects on kidneyfunction.Cochrane Database Syst Rev 2010:CD007594.
42. Haase M, Haase-Fielitz A, Bellomo R, et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 2009; 37:39-47.
43. Brogden RN, Markham A. Fenoldopam. A review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the manage-mentofhypertensive urgenciesand emergencies. Drugs 1997;54:634-650.
44. Landoni G, Biondi-Zoccai GG, Tumlin JA, et al. Beneficial impact of fenoldo-pam in critically ill patientswith oratriskforacute renalfailure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 2007; 49:56-68.
45. Landoni G, Biondi-Zoccai GG, Marino G, et al. Fenoldopam reduces the need for renal replacementtherapy and in-hospital death in cardiovascularsurgery: a meta-analysis. J Cardiothorac Vasc Anesth 2008; 22:27-33.
46. Edelstein CL, Ling H, Wangsiripaisan A, Schrier RW. Emerging therapies for acute renal failure. Am J Kidney Dis 1997; 30:89-95.
47. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev 2009:CD006028.
48. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
49. Lecomte P, Van VB, Coddens J, et al. Tight perioperative glucose control is associated withareduction in renal impairmentand renalfailure in nondiabetic cardiac surgical patients. Crit Care 2008; 12:R154.
50. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
51. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICESUGAR study data. CMAJ 2009; 180:821-827.
52. Ghahramani N, Shadrou S, Hollenbeak C. A systematic review of continuous renal replacement therapy and intermittent haemodialysis in management of patientswith acute renal failure. Nephrology 2008; 13:570-578.
53. Shiao CC, Wu VC, Li WY, et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care 2009; 13:R171.
54. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009; 301:2445-2452.
55. Nakamura T, Kawagoe Y, Matsuda T, et al. Effectsof polymyxin B-immobilized fiber on urinary Λ/-acetyl-B-glucosaminidase in patients with severe sepsis. ASAIO J 2004; 50:563-567.
56. Cantaluppi V, Assenzio B, Pasero D, et al. Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 2008; 34:1638-1645.